Humanetics extends long COVID drug trial to more sites
Humanetics has expanded clinical trial of a new oral drug, BIO 300, for long-haul Covid-19 (long COVID) to include two more US study sites.
New York United States Michael Kaytor Centric Services For Houston Methodist Research Institute National Institute Of Allergy
Source: clinicaltrialsarena.com